David Larsen
Stock Analyst at BTIG
(2.36)
# 3,051
Out of 5,182 analysts
112
Total ratings
45.65%
Success rate
-1.35%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Reiterates: Buy | $10 | $5.09 | +96.46% | 6 | May 4, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $55 → $65 | $53.54 | +21.40% | 8 | May 4, 2026 | |
| HSIC Henry Schein | Initiates: Neutral | n/a | $72.02 | - | 6 | Apr 16, 2026 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $4.08 | +71.57% | 2 | Mar 9, 2026 | |
| MDLN Medline | Reiterates: Buy | $55 | $44.19 | +24.46% | 2 | Mar 9, 2026 | |
| PGNY Progyny | Maintains: Buy | $35 → $30 | $18.91 | +58.65% | 5 | Mar 5, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $8 | $3.99 | +100.50% | 9 | Feb 25, 2026 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | n/a | $27.27 | - | 4 | Feb 24, 2026 | |
| HQY HealthEquity | Maintains: Buy | $130 → $110 | $82.18 | +33.85% | 6 | Feb 17, 2026 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $37 → $40 | $27.65 | +44.67% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $50 | $24.89 | +100.88% | 3 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $7.27 | +51.31% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $34.98 | +14.35% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.15 | - | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $2.85 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $26.94 | - | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $170.22 | +99.74% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $10.21 | +46.91% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.57 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $160.94 | +61.55% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.03 | +579.61% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.68 | +933.97% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $43.44 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $24.24 | +44.39% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.63 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.42 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $197.06 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $807.85 | -80.19% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $82.01 | +3.65% | 3 | Feb 9, 2018 |
LifeMD
May 4, 2026
Reiterates: Buy
Price Target: $10
Current: $5.09
Upside: +96.46%
BrightSpring Health Services
May 4, 2026
Maintains: Buy
Price Target: $55 → $65
Current: $53.54
Upside: +21.40%
Henry Schein
Apr 16, 2026
Initiates: Neutral
Price Target: n/a
Current: $72.02
Upside: -
The Oncology Institute
Mar 9, 2026
Reiterates: Buy
Price Target: $7
Current: $4.08
Upside: +71.57%
Medline
Mar 9, 2026
Reiterates: Buy
Price Target: $55
Current: $44.19
Upside: +24.46%
Progyny
Mar 5, 2026
Maintains: Buy
Price Target: $35 → $30
Current: $18.91
Upside: +58.65%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $3.99
Upside: +100.50%
Hims & Hers Health
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $27.27
Upside: -
HealthEquity
Feb 17, 2026
Maintains: Buy
Price Target: $130 → $110
Current: $82.18
Upside: +33.85%
Consensus Cloud Solutions
Feb 17, 2026
Maintains: Buy
Price Target: $37 → $40
Current: $27.65
Upside: +44.67%
Feb 6, 2026
Maintains: Buy
Price Target: $80 → $50
Current: $24.89
Upside: +100.88%
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $7.27
Upside: +51.31%
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $34.98
Upside: +14.35%
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $15.15
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.85
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $26.94
Upside: -
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $170.22
Upside: +99.74%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $10.21
Upside: +46.91%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.57
Upside: -
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $160.94
Upside: +61.55%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $1.03
Upside: +579.61%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.68
Upside: +933.97%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $43.44
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $24.24
Upside: +44.39%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.63
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $6.42
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $197.06
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $807.85
Upside: -80.19%
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $82.01
Upside: +3.65%